dMMR Colorectal Carcinoma — Trials

dMMR Colorectal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

12 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Ismail Gögenur
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06152523	Monalizumab and MEDI5752 in Patients With MSI and/or dMMR Metastatic Cancer(MONAMI)	withdrawn	Phase 2	0	Assistance Publique - Hôpitaux de ParisOTHER	1	Apr 6, 2026	clinicaltrials

Data updated 23 days agoSource updated Apr 6, 2026source: clinicaltrials